Skip to main content
Top
Published in: European Spine Journal 7/2012

Open Access 01-07-2012 | Original Article

Financial disclosures of authors involved in spine research: an underestimated source of bias

Authors: Ronald H. M. A. Bartels, Hans Delye, Jeroen Boogaarts

Published in: European Spine Journal | Issue 7/2012

Login to get access

Abstract

Background

Reporting financial disclosures has become standard practice in both journal publications and during oral forum at scientific meetings. Despite this, the effect of reporting a financial disclosure of any member of an authorgroup, on the tone of the conclusion of an article has gained little attention. This study was performed to determine what effect reporting a financial disclosure has on the conclusion of an article.

Methods

A literature search for all articles on interspinous devices and cervical disc prostheses, published from January 1st, 2008 until December 1st, 2010 was performed. Financial disclosures were reported, as were funding by commercially active parties. The tone of the conclusions was graded as positive, neutral or negative.

Results

The odds ratio (OR) for a positive conclusion in cases where a financial disclosure was reported was 16.5 (95% CI: 4.7–58.1). Effect modification occurs with the presence of funding by a commercially active party. In cases where a financial disclosure was reported and funding was available for the study, the OR was 1.0 (95% CI: 0.08–12.6), whilst the OR was 33.3 (95%CI: 4.2–262.3) if funding was not provided. This discrepancy is mainly due to the large number of articles with a neutral/negative conclusion if the authors failed to report any financial disclosure and were not funded by a commercially active party.

Conclusions

Reporting a financial disclosure is a potential source of bias. Authors with disclosed financial relationships less often publish articles with a neutral/negative conclusion. This source of bias should certainly be taken into account during the critical appraisal of articles, particularly when the quality of the literature is being assessed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Irwin RS (2009) The role of conflict of interest in reporting of scientific information. Chest 136:253–259PubMedCrossRef Irwin RS (2009) The role of conflict of interest in reporting of scientific information. Chest 136:253–259PubMedCrossRef
2.
go back to reference Morin K, Rakatansky H, Riddick FA Jr et al (2002) Managing conflicts of interest in the conduct of clinical trials. JAMA 287:78–84PubMedCrossRef Morin K, Rakatansky H, Riddick FA Jr et al (2002) Managing conflicts of interest in the conduct of clinical trials. JAMA 287:78–84PubMedCrossRef
3.
go back to reference Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454–465PubMedCrossRef Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454–465PubMedCrossRef
4.
go back to reference Lexchin J, Bero LA, Djulbegovic B et al (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167–1170PubMedCrossRef Lexchin J, Bero LA, Djulbegovic B et al (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167–1170PubMedCrossRef
5.
go back to reference Shah RV, Albert TJ, Bruegel-Sanchez V et al (2005) Industry support and correlation to study outcome for papers published in Spine. Spine 30:1099–1104PubMedCrossRef Shah RV, Albert TJ, Bruegel-Sanchez V et al (2005) Industry support and correlation to study outcome for papers published in Spine. Spine 30:1099–1104PubMedCrossRef
6.
go back to reference Rampton S, Stauber J (2002) Research funding, conflicts of interest, and the meta-methodology of public relations. Public Health Rep 117:331–339PubMed Rampton S, Stauber J (2002) Research funding, conflicts of interest, and the meta-methodology of public relations. Public Health Rep 117:331–339PubMed
7.
go back to reference Riechelmann RP, Wang L, O’Carroll A et al (2007) Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25:4642–4647PubMedCrossRef Riechelmann RP, Wang L, O’Carroll A et al (2007) Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25:4642–4647PubMedCrossRef
8.
go back to reference Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56PubMedCrossRef Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56PubMedCrossRef
9.
go back to reference Kofke WA (2010) Disclosure of industry relationships by anesthesiologists: is the conflict of interest resolved? Curr Opin Anaesthesiol 23:177–183PubMedCrossRef Kofke WA (2010) Disclosure of industry relationships by anesthesiologists: is the conflict of interest resolved? Curr Opin Anaesthesiol 23:177–183PubMedCrossRef
10.
go back to reference Ju BL, Miller CP, Whang PG et al (2011) Quantifying the variability of financial disclosure information reported by authors presenting at annual spine conferences. Spine J 11:1–8PubMedCrossRef Ju BL, Miller CP, Whang PG et al (2011) Quantifying the variability of financial disclosure information reported by authors presenting at annual spine conferences. Spine J 11:1–8PubMedCrossRef
11.
go back to reference Keune JD, Vig S, Hall BL et al (2011) Taking disclosure seriously: disclosing financial conflicts of interest at the American college of surgeons. J Am Coll Surg 212:215–224PubMedCrossRef Keune JD, Vig S, Hall BL et al (2011) Taking disclosure seriously: disclosing financial conflicts of interest at the American college of surgeons. J Am Coll Surg 212:215–224PubMedCrossRef
12.
go back to reference Italian Medicines Agency (AIFA) Research, Development Working Group (2010) Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience. Eur J Clin Invest 40:69–86CrossRef Italian Medicines Agency (AIFA) Research, Development Working Group (2010) Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience. Eur J Clin Invest 40:69–86CrossRef
Metadata
Title
Financial disclosures of authors involved in spine research: an underestimated source of bias
Authors
Ronald H. M. A. Bartels
Hans Delye
Jeroen Boogaarts
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
European Spine Journal / Issue 7/2012
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-011-2086-x

Other articles of this Issue 7/2012

European Spine Journal 7/2012 Go to the issue